AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18554862
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of soy isoflavones and 17-beta-estradiol
Trial: 8244135
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg gliadin (group A)
Trial: 8244135
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg gliadin (group B)
Trial: 3513568
Drug: High-dose folic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose folic acid (250 mg per day for 3 months)
Trial: 31304600
Drug: Two-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose regimen (625 IU anti-D at 28 and 34 weeks)
Trial: 9164228
Drug: Two-dose regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose regimen
Trial: 27651506
Drug: Crushed intranasal
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed intranasal ER morphine
Trial: 29849845
Drug: Morphine ARER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine ARER
Trial: 27776098
Drug: Adductor canal
RxNorm normalized name: Canalevia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adductor canal blockade with 10 mL of bupivacaine 0.25% with epinephrine 1:300,000
Trial: 11167480
Drug: Intravenous Buscopan
RxNorm normalized name: Buscopan
DrugBank: Butylscopolamine (DB09300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Buscopan 20 mg
Trial: 9571344
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (LIS) injected 20 min before the meal
Trial: 9571344
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (LIS) injected 15 min after the meal
Trial: 9571344
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (REG) injected 40 min before the meal
Trial: 9571344
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (REG) injected 20 min before the meal
Trial: 9571344
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (REG) injected immediately before the meal
Trial: 7831946
Drug: Rapid Infusion
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid Infusion system (Haemonetics Corp., Braintree, MA)
Trial: 7831946
Drug: Conventional iv
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional iv volume administration (37 degrees C) using pressure infusion bags
Trial: 26341720
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training in combination with nutrient supplementation (RTS)
Trial: 16608953
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) at 20 ppm for 12 hours
Trial: 25140772
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no inhaled nitric oxide)
Trial: 7547087
Drug: Tenidap sodium
RxNorm normalized name: tenidap sodium
DrugBank: Tenidap (DB13481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenidap sodium 120 mg with antacid (Maalox)
Trial: 7547087
Drug: Tenidap sodium
RxNorm normalized name: tenidap sodium
DrugBank: Tenidap (DB13481)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenidap sodium 120 mg fasting
Trial: 2179584
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered bacterial extract
Trial: 23278131
Drug: Doxycycline monotherapy
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline monotherapy PO
Trial: 21367495
Drug: Low glucose
RxNorm normalized name: ONE TOUCH LOW GLUCOSE CONTROL SOLN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low glucose intake (2.5 mg kg(‐1) min(‐1))
Trial: 21367495
Drug: Standard glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard glucose intake (5.0 mg kg(‐1) min(‐1))
Trial: 21367495
Drug: Standard amino
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard amino acid intake (1.5 g kg(‐1) day(‐1))
Trial: 21367495
Drug: High amino
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High amino acid intake (3.0 g kg(‐1) day(‐1))
Trial: 21367495
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (80 mU m(‐2) min(‐1))
Trial: 19722799
Drug: SRP +
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SRP + Xan‐CHX gel treatment
Trial: 19722799
Drug: SRP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP treatment
Trial: 9280178
Drug: Linseed oil
RxNorm normalized name: linseed oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linseed oil (average ALA intake: 5.9 g/d)
Trial: 26003683
Drug: Conjugated Linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated Linoleic Acid (CLA) 4 × 0.8 g day(‐1)
Trial: 2859043
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg betaxolol
Trial: 31262573
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of tramadol 1 mg/kg (group T)
Trial: 9117452
Drug: Dextrin sulphate
RxNorm normalized name: Dextrin sulphate
DrugBank: Dextrin 2-sulfate (DB06496)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextrin sulphate (D2S) gel
Trial: 8174967
Drug: CCK‐33 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCK‐33 (0.5 IDU.kg‐1.h‐1) during 15 mmol/l hyperglycaemia
Trial: 8174967
Drug: CCK‐33 (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCK‐33 (1.0 IDU.kg‐1.h‐1) during 15 mmol/l hyperglycaemia
Trial: 3956116
Drug: Gold therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gold therapy (Auromyose) in the same dosage schedule as before the study
Trial: 3956116
Drug: Placebo (gold
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (gold in a suspension diluted 1/100)
Trial: 29208618
Drug: Methylphenidate (20
RxNorm normalized name: methylphenidate (20/80 release) 25 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (20 mg two times per day)
Trial: 17577462
Drug: Manidipine 10
RxNorm normalized name: manidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manidipine 10 mg/d
Trial: 17577462
Drug: Delapril 30
RxNorm normalized name: Delapril
DrugBank: Delapril (DB13312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delapril 30 mg/d
Trial: 17577462
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Manidipine and Delapril
Trial: 2212409
Drug: Regular use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular use of aqueous beclomethasone diproprionate nasal spray
Trial: 2212409
Drug: As required
RxNorm normalized name: rabies vaccine, for intramuscular injection RETIRED CODE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: As required use of aqueous beclomethasone diproprionate nasal spray
Trial: 27789268
Drug: 1-day antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1-day antibiotic regimen (group B)
Trial: 25329681
Drug: Salmeterol/Fluticasone Propionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol/Fluticasone Propionate Combination (SFC) 50/100 µg once daily for 12 weeks
Trial: 22092536
Drug: Paracetamol (APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (APAP 1 g) + Saline (placebo)
Trial: 22092536
Drug: Paracetamol (APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (APAP 1 g) + Naloxone (Nal 8 mg)
Trial: 22092536
Drug: Placebo (pl)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (pl) + Naloxone (Nal 8 mg)
Trial: 31744796
Drug: PBS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PBS treatment
Trial: 21854752
Drug: Clodronate (CLO)
RxNorm normalized name: Clodronic acid
DrugBank: Clodronic acid (DB00720)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (CLO) treatment
Trial: 19473513
Drug: PACAM nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PACAM nutrition supplement
Trial: 7539635
Drug: FK 506
RxNorm normalized name: FK-960
DrugBank: FK-960 (DB06465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FK 506 (tacrolimus) at a starting dose of 0.15 mg/kg/day for 12 months
Trial: 30654054
Drug: SQ tree
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ tree SLIT-tablet
Trial: 7854920
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g i.v. acetazolamide
Trial: 2671560
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months supervised daily RMP 600 mg, ETH 500 mg and DDS 100 mg or CLO 100 mg
Trial: 23891363
Drug: Fenofibric acid
RxNorm normalized name: Fenofibric Acid
DrugBank: Fenofibric acid (DB13873)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenofibric acid (FA) 45 mg + Rosuvastatin (R) 5 mg for 8 weeks, then 10 mg for 8 additional weeks
Trial: 23891363
Drug: Rosuvastatin (R)
DrugBank: Rosuvastatin (DB01098)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rosuvastatin (R) 5 mg for 8 weeks, then 10 mg for 8 additional weeks
Trial: 19484433
Drug: IDD Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDD Therapy (Intervertebral Differential Dynamics Therapy) with traction weight systematically increased until 50% of a person's body weight plus 4.45 kg (10 lb) was reached.
Trial: 19484433
Drug: IDD Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDD Therapy and SHAM group (both groups received standard conservative therapeutic care and 20 sessions).
Trial: 16624438
Drug: Insulin sensitivity
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin sensitivity formula proposed by McAuley
Trial: 12177686
Drug: Galantamine 24
RxNorm normalized name: galantamine 24 mg oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine 24 mg/day
Trial: 14560062
Drug: Galantamine (continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (continuous treatment)
Trial: 2008110
Drug: Low-dose allopurinol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose allopurinol (total dose 1200 mg)
Trial: 2008110
Drug: High-dose allopurinol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose allopurinol (total dose 2400 mg)
Trial: 18290855
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg
Trial: 21991729
Drug: Dexmedetomidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1 microg/kg bolus followed by 0.4 microg/kg/hr infusion)
Trial: 11641075
Drug: Intrarectal quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrarectal quinine (QIR) 20 mg/kg in solution with 2 ml of water, followed by 15 mg/kg/8 h for cerebral malaria; 30 mg/kg followed by 20 mg/kg/12 h for severe malaria.
Trial: 7906384
Drug: Didanosine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine (500 mg per day)
Trial: 7906384
Drug: Zalcitabine (2.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zalcitabine (2.25 mg per day)
Trial: 1982648
Drug: Potenlini treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potenlini treatment (daily intravenous drip of 60‐100 ml for 3 days)
Trial: 1982648
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (other measures of treatment same as therapeutic group)
Trial: 9385238
Drug: Closed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed treatment
Trial: 19846008
Drug: Low-tidal-volume subgroup
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-tidal-volume subgroup (V(T)e ≤6 ml/kg)
Trial: 11686231
Drug: Acid-suppressant treatment
RxNorm normalized name: undecylenic acid Topical Solution [Hongo Killer Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acid-suppressant treatment alone (lansoprazole)
Trial: 9231834
Drug: Lisinopril (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (10, 20, or 40 mg)
Trial: 8136647
Drug: Mixt. 716
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixt. 716 treatment group
Trial: 3524840
Drug: Etretinate therapy
RxNorm normalized name: etretinate
DrugBank: Etretinate (DB00926)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etretinate therapy (4 months)
Trial: 3524840
Drug: Placebo (after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (after etretinate therapy)
Trial: 29504793
Drug: Internet-delivered cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered cognitive-behavioral treatment (ICBT) with systematic exposure
Trial: 22052452
Drug: ronacaleret 100
RxNorm normalized name: Ronacaleret
DrugBank: Ronacaleret (DB05255)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ronacaleret 100 mg once daily
Trial: 22052452
Drug: teriparatide 20
RxNorm normalized name: TERIPARATIDE 200UNT/VIL INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teriparatide 20 µg subcutaneously once daily
Trial: 22052452
Drug: alendronate 70
RxNorm normalized name: ALENDRONATE 70MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alendronate 70 mg once weekly
Trial: 27660922
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy (twice a day for 5 days)
Trial: 27059671
Drug: HydE (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HydE (9 g daily for 6 months)
Trial: 24311763
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg daily for 3 months followed by 200 mg daily for 21 months
Trial: 22912452
Drug: Nicarbazin (NCZ)
RxNorm normalized name: Nicarbazin
DrugBank: Nicarbazin (DB11434)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicarbazin (NCZ) at 125 mg/kg
Trial: 15823830
Drug: Relcovaptan (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relcovaptan (400 mg)
Trial: 9578817
Drug: Radioiodine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine treatment (RAI) with a median dose of 555 MBq
Trial: 16397182
Drug: Thrombolytic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrombolytic treatment
Trial: 2518859
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg famotidine nightly
Trial: 23850859
Drug: Service brokerage
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Service brokerage intervention (personalised booklet and weekly telephone contact for 4 weeks post-release)
Trial: 19365397
Drug: Prophylactic heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic heparin (study group)
Trial: 18091183
Drug: Ahmed glaucoma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ahmed glaucoma implant with mitomycin C (AGI+MMC)
Trial: 8044941
Drug: ranolazine 120
RxNorm normalized name: Ranolazine
DrugBank: Ranolazine (DB00243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranolazine 120 mg tid
Trial: 8044941
Drug: ranolazine 30
RxNorm normalized name: Ranolazine
DrugBank: Ranolazine (DB00243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranolazine 30 mg tid
Trial: 8044941
Drug: ranolazine 60
RxNorm normalized name: Ranolazine
DrugBank: Ranolazine (DB00243)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ranolazine 60 mg tid
Trial: 3378659
Drug: Netilmicin administered
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin administered intravenously or intramuscularly every 12 h at a dosage of 2.0-4.4 mg/kg (mean 3.5 mg/kg) for 5-15 days (mean 11 days)
Trial: 3378659
Drug: Netilmicin administered
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin administered intravenously or intramuscularly
Trial: 3378659
Drug: Netilmicin therapy
RxNorm normalized name: netilmicin
DrugBank: Netilmicin (DB00955)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Netilmicin therapy
Trial: 28377394
Drug: Zolpidem tartrate
RxNorm normalized name: Zolpidem Tartrate
DrugBank: Zolpidem (DB00425)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zolpidem tartrate (ZT) tablet plus SZRD granule placebo
Trial: 22867037
Drug: High-dose alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose alcohol (0.8 g/kg)
Trial: 12618532
Drug: Interferon‐α-2b (INF‐α)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon‐α-2b (INF‐α) and ribavirin therapy
Trial: 3805473
Drug: CO2 laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2 laser treatment
Trial: 10375932
Drug: LLETZ treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LLETZ treatment
Trial: 1997835
Drug: Radiation plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation plus fluorouracil (combined therapy)
Trial: 16128369
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg) added to ACE inhibitor therapy
Trial: 16128369
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (ACE inhibitors only)
Trial: 10325520
Drug: placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (1 tablet/day)
Trial: 10325520
Drug: finasteride (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: finasteride (5 mg/day)
Trial: 31724147
Drug: Dysphagia therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dysphagia therapy (original treatment method)
Trial: 26170625
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg twice a day)
Trial: 21900636
Drug: Minocycline 100
RxNorm normalized name: minocycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minocycline 100 mg orally every 12 hours
Trial: 8549581
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (C, 0.4 g.kg‐1 body mass)
Trial: 8549581
Drug: Placebo (P,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (P, sodium chloride 0.045 g.kg‐1 body mass)
Trial: 11725826
Drug: Conjugated linoleic
RxNorm normalized name: CONJUGATED LINOLEIC ACID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated linoleic acid (CLA) 0.6 g, three times daily, for 12 weeks
Trial: 25926408
Drug: Fine+LBG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fine+LBG treatment (smaller, 0.4-μm mean droplet size with LBG)
Trial: 25926408
Drug: Coarse treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coarse treatment (larger, 6-μm mean droplet size)
Trial: 24282895
Drug: Information leaflet
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Information leaflet on antibiotics with delayed prescription
Trial: 17356139
Drug: Topical fibrin
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical fibrin spray
Trial: 9819070
Drug: Sertraline hydrochloride
RxNorm normalized name: sertraline hydrochloride
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline hydrochloride (50-200 mg/d)
Trial: 661730
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg benzbromarone (Normurat)
Trial: 7175716
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g probenecid
Trial: 19701833
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of levothyroxine and liothyronine for at least 4 months
Trial: 8067759
Drug: Ofloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ofloxacin (200 mg twice a day)
Trial: 15239254
Drug: Pravastatin (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40-80 mg)
Trial: 15239254
Drug: Gemcitabine (80-90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine (80-90 mg/m2 over 24 hours weekly in cycles of 4 weeks)
Trial: 12362007
Drug: Home-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based intervention program including physical therapy